Synapse — Law for Life Sciences, May 2013

This month’s Synapse includes articles on:

  • outsourcing the manufacture of drugs;
  • reimbursement of biosimilars;
  • UK tax relief for R&D; pensions — there is no alternative;
  • why do we need data-protection policies?;
  • R&D tax relief — the SME scheme;
  • and R&D tax relief — the large company scheme.

If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.

 

Briefings from Taylor Wessing

View more briefings from Taylor Wessing

Analysis from The Lawyer

  • singapore orchid

    Singapore: Cash course

    The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world

  • Money 317

    Crunch boom

    Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town

View more analysis from The Lawyer

Overview

5 New Street Square
London
EC4A 3TW
UK
http://www.taylorwessing.com

Turnover (£m): 228.00
No. of Lawyers: 860
No. of Lawyers (Asia Pacific): 79
Offices (Asia Pacific): 3

Jobs